1338-1339 / 2605
Recent studies of particle therapy for HCC (3/2011 - )
*Locoregional progression-free survival.
†All pa6ents with portal vein tumor thrombosis.
‡Pa6ents received ≤42.8 GyE and 45 GyE.
§Tumors adjacent to GI tract.
1. Kim TH, Park JW, Kim YJ et al. Cancer Res Treat 2015; 47: 34-45.
2. Mizumoto M, et al. Radiother Oncol 2014; 113: 54-59.
3. Lee SU, Park JW, Kim TH et al. Strahlenther Onkol 2014; 190: 806-814.
4. Nakayama H, et al. Int J Radiat Oncol Biol Phys 2011; 80: 992-995.
5. Kawashima M, et al. Int J Radiat Oncol Biol Phys 2011; 79: 1479-1486.
High local control
Low toxicity
Protons = carbon ions